285 related articles for article (PubMed ID: 30987915)
1. Throwing it in reverse: An update on reversal of oral factor Xa inhibitors.
Gilbert BW; Reeder JA; Alkhalifah MA; Moran DA; Corvino MA
Am J Emerg Med; 2019 Oct; 37(10):1978-1980. PubMed ID: 30987915
[No Abstract] [Full Text] [Related]
2. [Andexanet alfa: the best antidote for factor Xa inhibitors?].
Klok FA; Huisman MV
Ned Tijdschr Geneeskd; 2019 Jun; 163():. PubMed ID: 31283119
[TBL] [Abstract][Full Text] [Related]
3. Andexanet alfa: a recombinant mimetic of human factor Xa for the reversal of anticoagulant therapies.
Escolar G; Diaz-Ricart M; Arellano-Rodrigo E
Drugs Today (Barc); 2017 May; 53(5):271-282. PubMed ID: 28650000
[TBL] [Abstract][Full Text] [Related]
4. Andexanet alfa for the reversal of anticoagulant activity in patients treated with direct and indirect factor Xa inhibitors.
Nafee T; Aslam A; Chi G; Pahlavani S; Nimri D; Kuchkuntla AR; Talib U; Michalak N; Daaboul Y; Korjian S; Gallo A; Gibson CM
Expert Rev Cardiovasc Ther; 2017 Apr; 15(4):237-245. PubMed ID: 28282497
[TBL] [Abstract][Full Text] [Related]
5. Preclinical and Clinical Data for Factor Xa and "Universal" Reversal Agents.
Milling TJ; Kaatz S
Am J Med; 2016 Nov; 129(11S):S80-S88. PubMed ID: 27575436
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical data for factor Xa and "universal" reversal agents.
Milling TJ; Kaatz S
Am J Emerg Med; 2016 Nov; 34(11S):39-45. PubMed ID: 27697443
[TBL] [Abstract][Full Text] [Related]
7. Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity.
Siegal DM; Curnutte JT; Connolly SJ; Lu G; Conley PB; Wiens BL; Mathur VS; Castillo J; Bronson MD; Leeds JM; Mar FA; Gold A; Crowther MA
N Engl J Med; 2015 Dec; 373(25):2413-24. PubMed ID: 26559317
[TBL] [Abstract][Full Text] [Related]
8. Universal, class-specific and drug-specific reversal agents for the new oral anticoagulants.
Ansell JE
J Thromb Thrombolysis; 2016 Feb; 41(2):248-52. PubMed ID: 26449414
[TBL] [Abstract][Full Text] [Related]
9. Andexanet alfa or prothrombin complex concentrate for acute reversal of oral factor Xa inhibitors: monitoring of antidote effects.
Tanaka KA; Levy JH
Br J Anaesth; 2024 Feb; 132(2):215-217. PubMed ID: 38071150
[TBL] [Abstract][Full Text] [Related]
10. When and How to Use Reversal Agents for Direct Oral Anticoagulants?
Gómez-Outes A; Suárez-Gea ML; Lecumberri R
Curr Cardiol Rep; 2023 May; 25(5):371-380. PubMed ID: 36976497
[TBL] [Abstract][Full Text] [Related]
11. Antidotes for reversal of direct oral anticoagulants.
Dobesh PP; Bhatt SH; Trujillo TC; Glaubius K
Pharmacol Ther; 2019 Dec; 204():107405. PubMed ID: 31521696
[TBL] [Abstract][Full Text] [Related]
12. Andexanet alfa-The first 150 days.
Culbreth SE; Rimsans J; Sylvester K; Pallin DJ; Connors JM
Am J Hematol; 2019 Jan; 94(1):E21-E24. PubMed ID: 30358896
[No Abstract] [Full Text] [Related]
13. Reversal agents for non-vitamin K antagonist oral anticoagulants.
Levy JH; Douketis J; Weitz JI
Nat Rev Cardiol; 2018 May; 15(5):273-281. PubMed ID: 29345686
[TBL] [Abstract][Full Text] [Related]
14. How can we reverse bleeding in patients on direct oral anticoagulants?
Crowther M; Cuker A
Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
[TBL] [Abstract][Full Text] [Related]
15. Idarucizumab and Factor Xa Reversal Agents: Role in Hospital Guidelines and Protocols.
Huisman MV; Fanikos J
Am J Med; 2016 Nov; 129(11S):S89-S96. PubMed ID: 27569673
[TBL] [Abstract][Full Text] [Related]
16. Andexanet Alfa Should Be Used to Reverse Factor Xa Inhibitors in the Setting of Life-Threatening Bleeding.
Brown CS; Gilbert BW
Ann Emerg Med; 2023 Sep; 82(3):364-365. PubMed ID: 36669921
[No Abstract] [Full Text] [Related]
17. Reversal of direct oral anticoagulants.
Zhang XY; Desborough MJ; Shapiro S
Br J Hosp Med (Lond); 2017 Mar; 78(3):165-169. PubMed ID: 28277769
[TBL] [Abstract][Full Text] [Related]
18. Outcomes Associated With 4-Factor Prothrombin Complex Concentrate Administration to Reverse Oral Factor Xa Inhibitors in Bleeding Patients.
Highsmith EA; Morton C; Varnado S; Donahue KR; Sulhan S; Lista A
J Clin Pharmacol; 2021 May; 61(5):598-605. PubMed ID: 33094836
[TBL] [Abstract][Full Text] [Related]
19. A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA).
Rogers KC; Finks SW
Am J Med; 2019 Jan; 132(1):38-41. PubMed ID: 30053385
[TBL] [Abstract][Full Text] [Related]
20. [Reversal strategies for non-vitamin K antagonist oral anticoagulants].
Larsen FU; Hvas AM; Grove EL
Ugeskr Laeger; 2016 Oct; 178(40):. PubMed ID: 27697119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]